Embed Size (px)
Citation preview
Trusted evidence.Informed decisions.Better health.
Promotion and prioritisation:
the Tobacco Addiction Group’s
20th anniversary project
Dr Nicola Lindson-Hawley
Managing EditorCochrane Tobacco Addiction GroupNuffield Department of Primary Care Health Sciences, University of Oxford
@cochraneTAG
Cochrane
Colloquium
Thursday 27th
October 2016
The Cochrane Tobacco Addiction Group (CTAG) is funded by the
National Institute for Health Research (NIHR)
The project presented here is funded by the NIHR School for Primary
Care Research
I am a Managing Editor for the Cochrane Tobacco Addiction Group and
author some of our reviews
I am collaborator on a completed NIHR funded smoking cessation trial.
The nicotine patch treatment was provided free of charge by
GlaxoSmithKline (GSK). GSK had no further involvement in the conduct
of the trial.
Disclosure
Focus on interventions for tobacco use & prevention
Funded by the National Institute for Health Research (NIHR)
Established 1996. 2016 is our 20th anniversary!
Cochrane Tobacco Addiction Group (CTAG)
Cochrane Tobacco Addiction Group (CTAG)
Editorial base at the Nuffield Department of Primary Care Health Sciences,
University of Oxford, UK
Jamie Hartmann-Boyce
Managing Editor
Nicola Lindson-Hawley
Managing Editor
Lindsay Stead
Managing Editor &
Information Specialist
Tim Lancaster
Co-ordinating Editor
Paul Aveyard
Editor, University of Oxford
Robert West
Editor, UCL
John Hughes
Editor, University of Vermont
CTAG’s aims
To inform tobacco control policy
internationally;
to inform research in tobacco control,
and help ensure new research is
focussed on important unanswered
questions;
to contribute to reducing tobacco use
The Cochrane TAG 20th anniversary priority
setting project (CTAG taps) Developed by CTAG & departmental Communications Manager
Funded by the NIHR School for
Primary Care Research
AIMS
1. Raise awareness
2. Identify where further tobacco control & smoking cessation research is
needed
3. Identify ways to effectively disseminate the findings of tobacco research
4. Identify specific goals for Cochrane TAG
Involving our stakeholders Until now CTAGs work has
mainly been informed by
researchers
Including others in decisions
about future directions will
enable findings to: 1) be better
applied to those who need them;
and 2) have a higher global impact
Inspired by the work of the James Lind Alliance
CTAG’s stakeholders:
Policy makers
Research fundersResearchers
Healthcare
providers
Current &
former smokersHealthcare
commissioners
Methods
Developed survey asking respondents to share a max. of 4 questions they would
like to see answered by tobacco control research in general
Aimed at anyone with an interest in tobacco (personal or professional)
presented to Nottingham smoker’s panel – adjusted in response to comments
Built in Survey Monkey to be accessed via internet link
Link disseminated via mailing lists, public health organisations, Twitter, Facebook,
conferences, blogging
Survey stage 1: Identifying uncertainties
Survey stage 1: Identifying uncertainties
Results
258 questions after duplicates removed
15 non-empirical
60 already answered - more effective dissemination needed?
183 unanswered questions identified!
Decisions made by at least 2 people independently
Research categories
Addressing inequalities Nicotine and tobacco risk
Alternative tobacco products Population level interventions
Digital interventions Pregnancy
E-cigarettes Smoking bans and second-hand smoke
Illness & chronic disease sufferers Smoking treatment methods excluding medications
Initiating quit attempts Treatment delivery
Medications Young people
Mental health and other substance abuse
Uncertainties classified into 15 research categories, containing 3-21 qs each
Methods
Survey developed asking respondents to:
1. rank the 15 research categories identified in Stage 1 in order of importance (prioritisation):
1= most important; 15= least important
2. Rank the questions within their top 3 categories (1=most important)
Checked by member of the public
Built in Survey Monkey to be accessed via internet link
Sent out to the 278 stage 1 respondents who provided full contact details via
Opportunity to win 1 of 3 Amazon vouchers
Survey stage 2: Ranking uncertainties
Survey stage 2: Ranking uncertainties 175 people completed the survey (63% of those invited)
Total ranks for each category/question were added together. Total scores were
ordered within their set and given an overall rank
Built on survey findings, focusing more
specifically on prioritisation for Cochrane
TAG
Where should CTAG focus their future
efforts?
How can we improve the dissemination of
our research findings?
Practical workshop session designed and
led by independent facilitation company-
Hopkin van Mil
Round table discussion; 7 per table +1
facilitator
Stage 3: Prioritisation Workshop
Setting the scene
Prioritising CTAG research & dissemination
Analyse workshop data: flip charts, audio recordings, delegate notes
Write-up as a report for publication in a scientific journal
Develop new review dissemination plan
Use findings to set CTAG priorities
Begin working on our priorities in 2017
Next steps
How to find out more or contact us
Visit our website: http://tobacco.cochrane.org/
Tweet us: @cochraneTAG
Email us: [email protected]
Call us: +44 (0)1865 289 320
National Institute for Health Research School for Primary Care Research (NIHR SPCR) is a partnership between the Universities of Bristol, Cambridge, Keele, Manchester, Newcastle, Nottingham, Oxford, Southampton and University College London. This presentation summarises independent research funded by the National Institute for Health Research School for Primary Care Research. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
